Rational modification of human synovial fluid phospholipase A2 inhibitors.
Pisabarro
M T
MT
European Molecular Biology Laboratory, Heidelberg, Germany.
Ortiz
A R
AR
Palomer
A
A
Cabré
F
F
García
L
L
Wade
R C
RC
Gago
F
F
Mauleón
D
D
Carganico
G
G
D001172:Arthritis, Rheumatoid / Q000188:drug therapy / Q000201:enzymology; D003460:Crystallization; D006801:Humans; D006860:Hydrogen Bonding; D008958:Models, Molecular; D015394:Molecular Structure; D010714:Phosphatidylethanolamines / Q000737:chemistry* / Q000378:metabolism / Q000494:pharmacology; D010741:Phospholipases A / Q000037:antagonists & inhibitors* / Q000737:chemistry / Q000378:metabolism; D054467:Phospholipases A2; D013582:Synovial Fluid / Q000201:enzymology*; D013816:Thermodynamics
D010714:Phosphatidylethanolamines; C066847:1-O-octyl-2-heptylphosphonylglycero-3-phosphoethanolamine; D010741:Phospholipases A; D054467:Phospholipases A2